GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.031
Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy
Kim1, H; Cho, WK; Kim, YJ; Kim, YS; Park, W

INT J MOL SCI 2020 10.3390/ijms21082691
Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation
Choi1, C; Cho, WK; Park, S; Shin, SW; Park, W; Kim, H; Choi, DH

CANCER RES TREAT 2020 10.4143/crt.2019.261
Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer
Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY

RADIAT ONCOL 2020 10.1186/s13014-020-1464-0
Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer
Yang1, K; Kim, H; Choi, DH; Park, W; Noh, JM; Cho, WK

CANCER RES TREAT 2020 10.4143/crt.2019.126
Clinical Outcomes of Postoperative Radiotherapy Following Radical Prostatectomy in Patients with Localized Prostate Cancer: A Multicenter Retrospective Study (KROG 18-01) of a Korean Population
Lee1, SU; Cho, KH; Park, W; Cho, WK; Kim, JS; Wee, CW; Kim, YS; Kim, JH; Nam, TK; Cho, J; Jeong, SM; Kim, Y; Shim, SJ; Choi, Y; Kim, JS

J CLIN MED 2019 10.3390/ijms20194943
Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation
Choi1, C; Park, S; Cho, WK; Choi, DH

BREAST 2019 10.1016/j.breast.2019.06.005
Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
Cho1, WK; Choi, DH; Park, W; Kim, H; Cha, H

J BREAST CANC 2019 10.4048/jbc.2019.22.e42
Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
Cho1, WK; Choi, DH; Park, W; Kim, H; Kim, S; Shin, MH; Cha, H

J RADIAT RES 2019 10.1093/jrr/rrz043
A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02)
Chung1, MJ; Cho, WK; Oh, D; Eom, KY; Kim, JH; Kim, WC; Lee, JH

INT J GYNECOL CANCER 2019 10.1136/ijgc-2019-000615
Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer
Cho1, WK; Kim, YI; Park, W; Yang, K; Kim, H; Cha, H

BREAST 2019 10.1016/j.breast.2019.02.010
Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16)
Cho1, WK; Park, W; Choi, DH; Kim, YB; Su, CO; Shin, KH; Chie, EK; Kim, JH; Ahn, SD; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ; Shin, HS; Lee, HS; Lee, NK

J BREAST CANC 2019 10.4048/jbc.2019.22.e25
The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
Cho1, WK; Park, W; Choi, DH; Kim, YB; Kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ

WORLD J GASTROENTERO 2019 10.3748/wjg.v25.i20.2416
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Choi1, C; Yoo, GS; Cho, WK; Park, HC

CANCER RES TREAT 2019 10.4143/crt.2018.240
Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients
Cho1, WK; Oh, D; Lee, E; Kim, TG; Lee, H; Nam, H; Noh, JM; Ahn, YC

RADIOTHER ONCOL 2019 10.1016/j.radonc.2019.01.005
Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery
Cho1, WK; Oh, D; Kim, HK; Ahn, YC; Noh, JM; Shim, YM; Zo, JI; Choi, YS; Sun, JM; Lee, SH; Ahn, MJ; Park, K; Nam, H

BREAST 2019 10.1016/j.breast.2018.11.004
Adjuvant radiation therapy in small ductal carcinoma in situ
Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H